Quick Answer
Chemours Co reported R&D Expense of $108.00 million for fiscal year 2025.
Chemours Co R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $108.00M | -0.9% |
| 2024 | $109.00M | +0.9% |
| 2023 | $108.00M | -8.5% |
| 2022 | $118.00M | +10.3% |
| 2021 | $107.00M | +15.1% |
| 2020 | $93.00M | +16.2% |
| 2019 | $80.00M | -2.4% |
| 2018 | $82.00M | +1.2% |
| 2017 | $81.00M | +0.0% |
| 2016 | $81.00M | -16.5% |
| 2015 | $97.00M | -32.2% |
| 2014 | $143.00M | -12.8% |
| 2013 | $164.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.00M | -10.3% | -7.1% |
| June 30, 2025 | $28.00M | +7.7% | +3.7% |
| March 31, 2025 | $27.00M | -3.6% | -6.9% |
| September 30, 2024 | $29.00M | +3.6% | +11.5% |
| June 30, 2024 | $26.00M | -7.1% | -7.1% |
| March 31, 2024 | $28.00M | +7.7% | +0.0% |
| September 30, 2023 | $28.00M | -12.5% | +0.0% |
| June 30, 2023 | $28.00M | +12.0% | +7.7% |
- Chemours Co showed a decrease of -0.9% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Chemours Co’s r&d expense has declined by 34.1% (from $164.00 million to $108.00 million).
- The most recent figure is from Chemours Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: